Are we there yet ? // a minor rewrite ... ** quick

New Post Public Reply Private Reply Replies (2) Message Board
WBeacham
563
Are we there yet ? // a minor rewrite ...

** quick note - the recent rise in sp bodes well, imo. Things do not happen in a vacuum. What comes to mind right away are two words, STADA & RecoveryRx. Shout out to Srinsocal for his dd on STADA. My guess only, remember, but a deal of that magnitude and reach ??? I get shivers thinking about it. Take heed the words of Mtoronto.

For the 2nd qtr 2021 it looks like we have a 3-fold increase in revenue from 1st qtr 2021, at a minimum (TAZZER, post #269042 on i-fraud). This is coming on the heels of "... Q4 2020 revenue exceeded $519,000; an increase of 241% when compared to Q3 2020 revenue of ($151,956) aaaannnd reread this ... https://www.bielcorp.com/bioelectronics-corpo...forecasts/. As Srinsocal (on i-fraud, post #269087) has pointed out, this does not include any shipments to the Rest-of-the-World (ROW), eg - Europe & Asia. The CE Mark was re-certified on 12 Nov 2020, opening up sales to 33+ countries in Europe alone. It also obtained MDSAP certification in Q1 2021, which allows for product distribution in Canada, Australia, and New Zealand.

Predictions come and go. Come to think of it, I don't think I have even come close to being correct. That's ok. It's the fun part. But there's no guesswork when it comes to what Bioelectronics represents to the medical community-at-large. We represent a paradigm shift. A new way of thinking about one's health that will transform your life in new and unexpected ways. Some already know, most don't. Not to worry b/c that is changing rapidly, as we speak, in exponential fashion. And believe me, I really do know what 'exponential' means. Put PEMF in the search engine. Educate yourself.

Big Pharma (BP) has long arms, deep pockets, a nasty temper and is well-connected. They don't tolerate nor have any patience with upstarts or new-fangled gadgets that don't fit into their agenda (lots of examples). Like it or not, believe it or not, the FDA, in all of its self-imposed officialdom, is a wholly-owned subsidary of Big Pharma. It was created, in the first place, to act as an official cover for their drug concoctions; to give them an imprimatur of legitimacy. There is nobody who wants to believe otherwise more than myself. Look at who has headed the agency from day one to get verification or at the many of the so-called 'scandals' spanning decades. There are few, if any, 'mistakes' or 'poor decision-making'. The current, ongoing opioid crisis is a prime example.

The medical field is loathe to innovation (again, lots of examples) unless it involves more pharmaceuticals, expensive surgeries, and more drugs, that's a given. The AMA took care of that decades ago with their decision to limit medical care to pills and surgery w/ few exceptions. Look up Morris Fishbein for an education. Not Wikipedia, dig a little deeper. As the saying goes - the truth is out there ... hint: it is well camouflaged and buried. The very same goes for the vaccine industry which has one of the most sordid histories one could ever imagine.

The point in bringing up all this unpleasant history is to put forth, perhaps, a more plausible backstory to our full body musculo-skeletal clearance. It would not have happened unless Big Pharma gave us, in the very least, a head nod, for it to go forward. Think of it as the 'Capo dei Capi' sanctioning, giving permission, so to speak, for it to proceed. Even gangsters can read the handwriting on the wall, to profit from societal trends. This 'go-ahead' has opened up everything and makes all things possibe going forward. In other words, we are on our way.

If the decision had been made on the merits of the science and tech alone, we would have been cleared ten (10) yrs earlier, as it was in Canada. I mean, honestly, we got turned down b/c it worked better on one gender vs the other ??? It'd be laughable if it weren't so tragic. In today's world, that kind of malicious folderol passes for science. The ugly truth is BP had not made enough blood money on their opioid products. Opioid comes from Opium (ref: heroin). They knew all along, right from the gitgo, what they were doing.

The possibility of a buyout might be a tad bit early but after we attain profitability and insurance coverage, it might be too late. I would wager at least one buyer has already emerged, made inquiries, and has started the long process. Let me be clear. I have no inside information and my comment is only a guess. One which I believe will come to fruition in the not-so-distant future. Lots of eyes on us and we are not hesitating to develop the business making us more valuable by the day. Our patented technology is worth billions, right now.

Andy Whelan gave his life for (t)his company; that's commitment. He knew what so many of us now know. PEMF, and all of its' derivative technologies, is the future of medicine. Having the ability to 'see' the future in any given endeavor is the key to success. Our Founder, Andy, is still with us in spirit and enjoying every moment of it. His daughter, Kelly, our CEO, is soldiering on, doing all she can to further and enhance his legacy. Of this I have no doubt whatsoever, despite the ranting and raving of a few malcontents, nevermind their suspect motivations.

Electro-Magnetism (E/M) is THE key to everything. The Powers-That-Be w/in the BP community have known for decades the beneficial effect E/M has on the human body, including the brain. Actipatch (vibrational therapy) is but one example as are acupuncture and infrared saunas. Western medicine, doled out to the masses that is, has always looked to overcome and conquer the body w/ drugs and surgery for obscene profits and marginal results. Far better to work with the body's own defenses and neural networks. Healthier outcomes, less disease & discomfort. Electroceuticals is the new paradigm and BP knows it and is preparing for it. Medical companies investing $$100s of millions, all within about 5 yrs, is not a random event.

Chakras, meridian lines, Chi (as in Tai Chi), Hinduism third eye are elusive concepts to grasp but 'oh-so-real' nonetheless. We inflate a football with air we cannot see. So the air doesn't exist? We choose to believe one but not the other. How does acupuncture work? Should you decide to investigate E/M (inside and outside the human body) you will discover some very interesting info that will challenge your most tightly held core beliefs. Talking about some real deep 'stuff' here. Or is Plato's Cave your permanent home?

"The future belongs to those who recognize opportunities before they become obvious" - Oscar Wilde. We are the right company with the right e/m products in the right place at the right time. It is about to become very, very obvious.

I'm liking our chances - WBeacham

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
PayPal Adds a Risk Hand to Its Board at a Crucial Turn

Updated Category News Views 91

A Boardroom Hire With Some Actual Weight PayPal did not go hunting for another decorative résumé. Brian J. Lee, set to join the board on November 30, 2026, spent decades inside Goldman Sachs, including a stint as chief risk officer from 2019 through January 2025. For a payments company trying to sharpen its financial-services identity, that is a serious piece of...

Continue Reading
S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 88

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading
Danaher and Microsoft Put AI Into the Lab Stack Early

Updated Category News Views 103

Laboratory AI gets interesting only when it reaches the hardware bench, and Danaher is taking a serious swing at that ugly, complicated job with Microsoft. The Nov. 20 partnership is not just another chatbot bolted onto a dashboard. It is aimed at building a common agentic platform that can help instruments interpret scientific intent, guide setup, control hardware within...

Continue Reading
YPTC’s Florida Office Bets on Nonprofit Finance Needs

Updated Category News Views 50

A Local Flag Planted After Years of Work Florida nonprofits do not need another consultant waving a glossy slide deck around; they need clean books, grant compliance, and somebody who can tell them where the cash is going before the lights start blinking red. That is the practical opening YPTC is chasing with a Jacksonville-based Florida office, its sixteenth office...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 78

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
RLX Revenue Soars, but European Margins Need Proof

Updated Category News Views 111

Revenue can wear a fancy suit while earnings arrive in work boots, and RLX Technology's third quarter is exactly that kind of report. The newly consolidated European distribution business pushed third-quarter revenue to RMB1.92 billion, up 69.7% year over year. That is a real jump, not pocket change. But the same acquisition also changed the mix, squeezed the blended...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 65

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 102

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 94

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Medical REIT Declares Significant 2024 Dividend Payments

Updated Category News Views 100

Global Medical REIT Inc. Announces 2024 Dividend Declares In an exciting update for shareholders, Global Medical REIT Inc. (NYSE: GMRE) has announced its board's decision to declare the 2024 fourth quarter common and preferred dividends. This revelation underscores the company's commitment to returning value to its investors, especially as it continues its growth...

Continue Reading
Predictive Dialer Software Market Growth and Insights for Businesses

Updated Category News Views 247

Rising Demand and Forecast for Predictive Dialer Software The predictive dialer software market is on an impressive trajectory, moving from a valuation of USD 2.6 billion to a staggering USD 45.1 billion in the coming years. This remarkable growth is primarily fueled by the increasing demand for telemarketing solutions and the rising number of automated contact centers...

Continue Reading
RWE and GE Vernova Collaborate for Energy Projects in the U.S.

Updated Category News Views 217

RWE Strengthens Partnership with GE Vernova for Sustainable Energy RWE has taken a significant step in advancing renewable energy in the U.S. by selecting GE Vernova as its trusted supplier for over 100 domestically produced wind turbines. This strategic decision will support two major energy projects, contributing 308 MW to the renewable energy grid. In doing so, RWE...

Continue Reading
Olin Corporation Reports Fourth Quarter Financial Highlights

Updated Category News Views 210

Olin Corporation's Financial Overview In a recent report, Olin Corporation (NYSE: OLN) disclosed its financial performance for the fourth quarter, showcasing a net income of $10.7 million, translating to $0.09 per diluted share. This figure reflects a decline compared to a net income of $52.9 million, or $0.43 per diluted share, seen in the corresponding quarter of the...

Continue Reading
Converge Technology Solutions Adjusts Dividend Payment Date

Updated Category News Views 214

Converge Technology Solutions Adjusts Dividend Payment Schedule Converge Technology Solutions Corp. (TSX: CTS) is set to enhance its dividend distribution process by moving the payment date forward due to holiday timings. Originally planned for December 28, 2024, shareholders can now expect to receive their dividend one day earlier, on December 27, 2024. This adjustment...

Continue Reading